ArticlePloS one2020
New insights into early MIS 5 lithic technological behavior in the Levant: Nesher Ramla, Israel as a case study.
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evidence from Tinshemet Cave in Israel suggests behavioural uniformity across Homo groups in the Levantine mid-Middle Palaeolithic circa 130,000-80,000 years ago.Nature human behaviour · 2025Article
- Expansion of eastern Mediterranean Middle Paleolithic into the desert region in early marine isotopic stage 5.Scientific reports · 2022Article
- No direct evidence for the presence of Nubian Levallois technology and its association with Neanderthals at Shukbah Cave.Scientific reports · 2022Article
- Directional changes in Levallois core technologies between Eastern Africa, Arabia, and the Levant during MIS 5.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interpreting human behavioral patterns during the Middle Paleolithic in the Levant is crucial for better understanding the dispersals and evolution of Homo sapiens and their possible interactions with other hominin groups. Here, we reconstruct the technological behavior, focusing on the centripetal Levallois method at Nesher Ramla karst sinkhole, Israel. Nesher Ramla karst sinkhole is dated to the Marine Isotope stages (MIS) 6 and 5 and represents one of the oldest occurrences of the centripetal Levallois reduction strategy in the Near East. The Levallois centripetal technology is often seen as a marker of human dispersals and adaptations in the Middle Paleolithic/Middle Stone Age of Africa and the Near East. This technology is documented in East African sites as early as 300 kya and in the Levant as early as 130 kya. However, the degree of similarity between African and Levantine centripetal technology and whether it originates from the same source remain under debate. In this paper, we focus on describing the lithic organization at Unit III of Nesher Ramla (dated to MIS 5), which is dominated by the centripetal Levallois method in association with other reduction sequences. Both preferential and recurrent centripetal Levallois modes were used at the site to produce oval and rectangular flakes. Other minor reduction sequences include unidirectional convergent method for Levallois points production and a specific method for the manufacture of naturally backed knives. The lithic data from Unit III of Nesher Ramla is further used in inter-site comparisons suggesting that the mid-Middle Paleolithic sites in the Near East possess common technological characteristics, especially the use of the centripetal Levallois method as predominant reduction strategy. This trend differs from what is usually observed in Africa and Europe, where the centripetal Levallois method is modestly represented during MIS 5 and is accompanied by other, more dominant, reduction strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.